- Home
- ENR vs NAMS Comparison
ENR vs NAMS Comparison
Compare ENR & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENR
- NAMS
- Stock Information
- Founded
- ENR 2015
- NAMS 2019
- Country
- ENR United States
- NAMS Netherlands
- Employees
- ENR N/A
- NAMS N/A
- Industry
- ENR Industrial Machinery/Components
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- ENR Miscellaneous
- NAMS Health Care
- Exchange
- ENR Nasdaq
- NAMS Nasdaq
- Market Cap
- ENR 2.5B
- NAMS 2.7B
- IPO Year
- ENR N/A
- NAMS N/A
- Fundamental
- Price
- ENR $29.65
- NAMS $23.58
- Analyst Decision
- ENR Hold
- NAMS Strong Buy
- Analyst Count
- ENR 8
- NAMS 7
- Target Price
- ENR $38.38
- NAMS $43.17
- AVG Volume (30 Days)
- ENR 635.4K
- NAMS 1.1M
- Earning Date
- ENR 05-06-2025
- NAMS 05-05-2025
- Dividend Yield
- ENR 4.07%
- NAMS N/A
- EPS Growth
- ENR N/A
- NAMS N/A
- EPS
- ENR 0.79
- NAMS N/A
- Revenue
- ENR $2,902,100,000.00
- NAMS $45,563,000.00
- Revenue This Year
- ENR $2.42
- NAMS N/A
- Revenue Next Year
- ENR $1.32
- NAMS $2.54
- P/E Ratio
- ENR $37.26
- NAMS N/A
- Revenue Growth
- ENR N/A
- NAMS 223.37
- 52 Week Low
- ENR $26.92
- NAMS $15.19
- 52 Week High
- ENR $39.52
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- ENR 34.78
- NAMS 62.05
- Support Level
- ENR $29.58
- NAMS $22.21
- Resistance Level
- ENR $31.78
- NAMS $23.89
- Average True Range (ATR)
- ENR 0.74
- NAMS 1.53
- MACD
- ENR 0.05
- NAMS 0.47
- Stochastic Oscillator
- ENR 17.12
- NAMS 90.78
About ENR Energizer Holdings Inc.
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.